(Total Views: 924)
Posted On: 06/27/2020 10:46:17 PM
Post# of 155004
From yahoo gonna be 4/5 posts after this one
Hi I am trying to figure out cost of sales... also how leronlimab got its pricing per dose...
From the 10k (annual report) it looks like 5% of net sales go to Progenics. And 2% to “Lonza Agreement”, and 3.5% to AbbVie, most of which last for 10 years.
The agreement with Samsung requires a $30 million (!) payment in 2020 alone.
Not to mention a 50% marketing agreement with Vyera for HIV at least.
But I have no idea what manufacture of leronlimb costs per dose. Also I have seen $2k per dose, if I recall, but no idea how CYDY selected that price.
Does anyone have more concrete info on cost of manufacture, other per-unit costs, and how Cytodyn selected its per-unit price? Can they choose whatever price the market will bear, or does that involve FDA or other agencies? Trying to understand profit potential vs gross sales.
Hi I am trying to figure out cost of sales... also how leronlimab got its pricing per dose...
From the 10k (annual report) it looks like 5% of net sales go to Progenics. And 2% to “Lonza Agreement”, and 3.5% to AbbVie, most of which last for 10 years.
The agreement with Samsung requires a $30 million (!) payment in 2020 alone.
Not to mention a 50% marketing agreement with Vyera for HIV at least.
But I have no idea what manufacture of leronlimb costs per dose. Also I have seen $2k per dose, if I recall, but no idea how CYDY selected that price.
Does anyone have more concrete info on cost of manufacture, other per-unit costs, and how Cytodyn selected its per-unit price? Can they choose whatever price the market will bear, or does that involve FDA or other agencies? Trying to understand profit potential vs gross sales.
(0)
(0)
